The Global Self-testing Market growth will be 5 5% CAGR during 2020-2030 pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.
Recent Developments - Importance and How to Use This Section
Importance of These Developments
FemtoDx Launches Rapid At-Home Test Development for COVID-19
FDA approves first at-home coronavirus test
Free Home HIV Tests Detect More Infections
Biohacking trend supports self testing.
PerkinElmer and EverlyWell to Expand U.S. At-Home Health Test Market
Mylan, Atomo Diagnostics Get WHO Prequalification Approval for HIV Self-Test
Miraca Holdings Inc. and Seventh Sense Biosystems, Inc. Announce Distribution Agreement
OraSure Technologies, Inc. Announces Two Acquisitions
Mylan signs HIV test commercialisation deal with Atomo Diagnostics
Nigerian Govt Approves Alere HIV Self-Test Kit
Rapid HIV tests vary in their accuracy
Global OTC/DTC Infectious Disease Diagnostics 2021-2024: COVID-19 to Lead the Change in the Market prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
4.3.3 Diagnostics Moves Out of the Hospital
4.3.4 Disruption Looms
5. PCR Recent Developments
5.1.1 Importance of These Developments
Scope Fluidics Secures €6.2M Supporting Rapid MDx
Quidel Expects SARS-CoV-2 Testing Demand to Continue Through 2022, and Beyond
Malaria Assays Use CRISPR for Point-of-Care Multispecies Detection
Fluidigm Saliva Test for SARS-CoV-2 Uses Extraction-free RT-PCR
Visby Medical Gonorrhea Test Wins $19M AMR Diagnostic Competition
HelixBind Receives $3M NIH Grant to Expand Bloodstream Infection Dx Platform
Israel s Nucleix Targeting US Market With Noninvasive Bladder, Lung Cancer Assays
Thermo Fisher Sees Many Complementary Offerings in Qiagen Combination
DxTerity Gets CE Mark for At-Home Blood Sample Collection Device
Fetal Cell-Based NIPT by Droplet Digital PCR Demonstrated in Japanese Pilot Study
Respiratory Syncytial Virus Diagnostic Testing Market Segment Analysis – By Geography
North America is the major region dominating the Respiratory Syncytial Virus Diagnostic Testing market with a market share of 42.16% in the year 2020. This can be attributed to the rising incidences of these infections and an increasing infant population over the forecast period 2021-2026. In order to produce companion diagnostics, increasing the number of strategic partnerships between pharmaceutical majors and in vitro diagnostic manufacturing companies are anticipated to make this a lucrative segment by signaling tremendous potential that could also be responsible for fueling the global RSV diagnostic testing market in the region.